Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myeloproliferation in long-term plasmacytoma-regressor mice.

International journal of cancer - 15 Jan 1994

Sagi-Assif O, Douer D, Shaked N, Russell S W, Witz I P

Abstract excerpt

MOPC-315 plasmacytoma-bearing BALB/c mice were treated with high doses of melphalan, causing a permanent and complete regression of the tumor. In the present study we analyzed plasmacytoma-regressor mice (PRM) 3-6 months after plasmacytoma regression. A second group of otherwise untreated normal mice was treated with melphalan (M--control group). A third group of mice remained untreated and served as an age- and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Division
Share to Cytokines
Share to TNF gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mice, Inbred BALB C

Share to Phenotype

Share to Spleen

Share to Time Factors

Source

Identifiers

PMID: 8314303
DOI: 10.1002/ijc.2910560211

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Myeloproliferation in long-term plasmacytoma-regressor mice.PMID 8314303Read ↗

Preleukemia in long-term plasmacytoma-regressor mice.Semantic proximity Read ↗

The marginating-pulmonary immune compartment in rats: characteristics of continuous inflammation and activated NK cells.Semantic proximity Read ↗

Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignanciesSemantic proximity Read ↗

Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis.Semantic proximity Read ↗

Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice.Semantic proximity Read ↗

The cellular cancer resistance of the SR/CR mouse.Semantic proximity Read ↗

Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy.Semantic proximity Read ↗

Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling.Semantic proximity Read ↗

Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.